Land: Nya Zeeland
Språk: engelska
Källa: Medsafe (Medicines Safety Authority)
Sulfacetamide sodium monohydrate 100 mg/mL
Allergan New Zealand Ltd
Sulfacetamide sodium monohydrate 100 mg/mL
10 %
Eye drops, solution
Active: Sulfacetamide sodium monohydrate 100 mg/mL Excipient: Benzalkonium chloride Dibasic sodium phosphate heptahydrate Hydrochloric acid Monobasic sodium phosphate monohydrate Polysorbate 80 Polyvinyl alcohol Purified water Sodium edetate Sodium hydroxide Sodium thiosulfate pentahydrate
Bottle, dropper, 15 mL
Restricted
Restricted
Katwijk Chemie BV
Package - Contents - Shelf Life: Bottle, dropper, - 15 mL - 18 months from date of manufacture stored at or below 25°C protect from light 4 weeks opened stored at or below 25°C protect from light
1969-12-31
BLEPH-10 ® sulfacetamide sodium Datasheet Version 2.0 DATA SHEET NAME OF MEDICINE BLEPH ® -10 EYE DROPS Sulfacetamide sodium 100mg/mL ophthalmic solution PRESENTATION Eyedrops: 10% with 1.4% polyvinyl alcohol (LIQUIFILM ® ), 0.005% benzalkonium chloride, polysorbate 80, sodium thiosulfate disodium edetate, dibasic sodium phosphate anhydrous, monobasic sodium phosphate heptahydrate, hydrochloric acid or sodium hydroxide to pH 7.4 and purified water. USES ACTIONS: The sulfonamides are bacteriostatic agents and the spectrum of activity is similar for all. Sulfonamides inhibit bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase. Resistant strains have altered dihydropteroate synthetase with reduced affinity for sulfonamides or produce increased quantities of aminobenzoic acid. Topically applied sulfonamides are considered active against susceptible strains of the following common bacterial eye pathogens: _Escherichia coli, Staphylococcus aureus, Streptococcus _ _pneumoniae, Streptococcus _(viridans group), _Haemophilus influenzae_, _Klebsiella _species and _Enterobacter_ species. Topically applied sulfonamides do not provide adequate coverage against _Neisseria_ species, _Serratia marcescens_ and _Pseudomonas aeruginosa. _A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. INDICATIONS Treatment of conjunctivitis, corneal ulcer, and other superficial ocular infections from susceptible micro-organisms and as an adjunct to systemic sulphonamide therapy of trachoma. DOSAGE AND ADMINISTRATION CONJUNCTIVITIS, CORNEAL ULCER AND SUPERFICIAL OCULAR INFECTIONS: One or two drops into lower conjunctival sac of the affected eye(s) every 2 or 3 h Läs hela dokumentet